CoA adducts of 4-oxo-4-phenylbut-2-enoates

Inhibitors of MenB from the M. tuberculosis menaquinone biosynthesis pathway

Xiaokai Li, Nina Liu, Huaning Zhang, Susan E. Knudson, Huei Jiun Li, Cheng Tsung Lai, Carlos Simmerling, Richard A. Slayden, Peter J. Tonge

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

A high-throughput screen led to the discovery of 2-amino-4-oxo-4- phenylbutanoate inhibitors of the 1,4-dihydroxy-2-naphthoyl-CoA synthase (MenB) from the menaquinone biosynthesis pathway in Mycobacterium tuberculosis. However, these compounds are unstable in solution and eliminate to form the corresponding 4-oxo-4-phenylbut-2-enoates that then react with CoA in situ to form nanomolar inhibitors of MenB. The potency of these compounds results from interaction of the CoA adduct carboxylate with the MenB oxyanion hole, a conserved structural motif in the crotonase superfamily. 4-Oxo-4- chlorophenylbutenoyl methyl ester has minimum inhibitory concentrations of 0.6 and 1.5 μg/mL against replicating and nonreplicating M. tuberculosis, respectively, and it is proposed that the methyl ester penetrates the cell where it is hydrolyzed and reacts with CoA to generate the active antibacterial. The CoA adducts thus represent an important foundation for the development of novel MenB inhibitors and suggest a general approach to the development of potent inhibitors of acyl-CoA binding enzymes.

Original languageEnglish (US)
Pages (from-to)818-823
Number of pages6
JournalACS Medicinal Chemistry Letters
Volume2
Issue number11
DOIs
StatePublished - Nov 10 2011
Externally publishedYes

Fingerprint

Vitamin K 2
Biosynthesis
Coenzyme A
Tuberculosis
Mycobacterium tuberculosis
Esters
Enoyl-CoA Hydratase
Acyl Coenzyme A
Microbial Sensitivity Tests
Throughput
Enzymes

Keywords

  • 1,4-dihydroxy-2-naphthoyl-CoA synthase
  • CoA
  • HTS
  • Menaquinone
  • MenB
  • o-succinylbenzoic acid

ASJC Scopus subject areas

  • Organic Chemistry
  • Drug Discovery
  • Biochemistry

Cite this

CoA adducts of 4-oxo-4-phenylbut-2-enoates : Inhibitors of MenB from the M. tuberculosis menaquinone biosynthesis pathway. / Li, Xiaokai; Liu, Nina; Zhang, Huaning; Knudson, Susan E.; Li, Huei Jiun; Lai, Cheng Tsung; Simmerling, Carlos; Slayden, Richard A.; Tonge, Peter J.

In: ACS Medicinal Chemistry Letters, Vol. 2, No. 11, 10.11.2011, p. 818-823.

Research output: Contribution to journalArticle

Li, X, Liu, N, Zhang, H, Knudson, SE, Li, HJ, Lai, CT, Simmerling, C, Slayden, RA & Tonge, PJ 2011, 'CoA adducts of 4-oxo-4-phenylbut-2-enoates: Inhibitors of MenB from the M. tuberculosis menaquinone biosynthesis pathway', ACS Medicinal Chemistry Letters, vol. 2, no. 11, pp. 818-823. https://doi.org/10.1021/ml200141e
Li, Xiaokai ; Liu, Nina ; Zhang, Huaning ; Knudson, Susan E. ; Li, Huei Jiun ; Lai, Cheng Tsung ; Simmerling, Carlos ; Slayden, Richard A. ; Tonge, Peter J. / CoA adducts of 4-oxo-4-phenylbut-2-enoates : Inhibitors of MenB from the M. tuberculosis menaquinone biosynthesis pathway. In: ACS Medicinal Chemistry Letters. 2011 ; Vol. 2, No. 11. pp. 818-823.
@article{ed67de9448df4f7a968e6afb48dc7761,
title = "CoA adducts of 4-oxo-4-phenylbut-2-enoates: Inhibitors of MenB from the M. tuberculosis menaquinone biosynthesis pathway",
abstract = "A high-throughput screen led to the discovery of 2-amino-4-oxo-4- phenylbutanoate inhibitors of the 1,4-dihydroxy-2-naphthoyl-CoA synthase (MenB) from the menaquinone biosynthesis pathway in Mycobacterium tuberculosis. However, these compounds are unstable in solution and eliminate to form the corresponding 4-oxo-4-phenylbut-2-enoates that then react with CoA in situ to form nanomolar inhibitors of MenB. The potency of these compounds results from interaction of the CoA adduct carboxylate with the MenB oxyanion hole, a conserved structural motif in the crotonase superfamily. 4-Oxo-4- chlorophenylbutenoyl methyl ester has minimum inhibitory concentrations of 0.6 and 1.5 μg/mL against replicating and nonreplicating M. tuberculosis, respectively, and it is proposed that the methyl ester penetrates the cell where it is hydrolyzed and reacts with CoA to generate the active antibacterial. The CoA adducts thus represent an important foundation for the development of novel MenB inhibitors and suggest a general approach to the development of potent inhibitors of acyl-CoA binding enzymes.",
keywords = "1,4-dihydroxy-2-naphthoyl-CoA synthase, CoA, HTS, Menaquinone, MenB, o-succinylbenzoic acid",
author = "Xiaokai Li and Nina Liu and Huaning Zhang and Knudson, {Susan E.} and Li, {Huei Jiun} and Lai, {Cheng Tsung} and Carlos Simmerling and Slayden, {Richard A.} and Tonge, {Peter J.}",
year = "2011",
month = "11",
day = "10",
doi = "10.1021/ml200141e",
language = "English (US)",
volume = "2",
pages = "818--823",
journal = "ACS Medicinal Chemistry Letters",
issn = "1948-5875",
publisher = "American Chemical Society",
number = "11",

}

TY - JOUR

T1 - CoA adducts of 4-oxo-4-phenylbut-2-enoates

T2 - Inhibitors of MenB from the M. tuberculosis menaquinone biosynthesis pathway

AU - Li, Xiaokai

AU - Liu, Nina

AU - Zhang, Huaning

AU - Knudson, Susan E.

AU - Li, Huei Jiun

AU - Lai, Cheng Tsung

AU - Simmerling, Carlos

AU - Slayden, Richard A.

AU - Tonge, Peter J.

PY - 2011/11/10

Y1 - 2011/11/10

N2 - A high-throughput screen led to the discovery of 2-amino-4-oxo-4- phenylbutanoate inhibitors of the 1,4-dihydroxy-2-naphthoyl-CoA synthase (MenB) from the menaquinone biosynthesis pathway in Mycobacterium tuberculosis. However, these compounds are unstable in solution and eliminate to form the corresponding 4-oxo-4-phenylbut-2-enoates that then react with CoA in situ to form nanomolar inhibitors of MenB. The potency of these compounds results from interaction of the CoA adduct carboxylate with the MenB oxyanion hole, a conserved structural motif in the crotonase superfamily. 4-Oxo-4- chlorophenylbutenoyl methyl ester has minimum inhibitory concentrations of 0.6 and 1.5 μg/mL against replicating and nonreplicating M. tuberculosis, respectively, and it is proposed that the methyl ester penetrates the cell where it is hydrolyzed and reacts with CoA to generate the active antibacterial. The CoA adducts thus represent an important foundation for the development of novel MenB inhibitors and suggest a general approach to the development of potent inhibitors of acyl-CoA binding enzymes.

AB - A high-throughput screen led to the discovery of 2-amino-4-oxo-4- phenylbutanoate inhibitors of the 1,4-dihydroxy-2-naphthoyl-CoA synthase (MenB) from the menaquinone biosynthesis pathway in Mycobacterium tuberculosis. However, these compounds are unstable in solution and eliminate to form the corresponding 4-oxo-4-phenylbut-2-enoates that then react with CoA in situ to form nanomolar inhibitors of MenB. The potency of these compounds results from interaction of the CoA adduct carboxylate with the MenB oxyanion hole, a conserved structural motif in the crotonase superfamily. 4-Oxo-4- chlorophenylbutenoyl methyl ester has minimum inhibitory concentrations of 0.6 and 1.5 μg/mL against replicating and nonreplicating M. tuberculosis, respectively, and it is proposed that the methyl ester penetrates the cell where it is hydrolyzed and reacts with CoA to generate the active antibacterial. The CoA adducts thus represent an important foundation for the development of novel MenB inhibitors and suggest a general approach to the development of potent inhibitors of acyl-CoA binding enzymes.

KW - 1,4-dihydroxy-2-naphthoyl-CoA synthase

KW - CoA

KW - HTS

KW - Menaquinone

KW - MenB

KW - o-succinylbenzoic acid

UR - http://www.scopus.com/inward/record.url?scp=80955150848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80955150848&partnerID=8YFLogxK

U2 - 10.1021/ml200141e

DO - 10.1021/ml200141e

M3 - Article

VL - 2

SP - 818

EP - 823

JO - ACS Medicinal Chemistry Letters

JF - ACS Medicinal Chemistry Letters

SN - 1948-5875

IS - 11

ER -